Alan W. Dunton - 26 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol
CRMD
Transactions as of
26 Jan 2026
Net transactions value
$0
Form type
4
Filing time
27 Jan 2026, 21:30:04 UTC
Previous filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DUNTON ALAN W Director C/O CORMEDIX INC., 389 INTERPACE PKWY, SUITE 450, PARSIPPANY /s/ Beth Zelnick Kaufman, attorney-in-fact 27 Jan 2026 0001304773

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Award $0 +30,453 +76% $0.000000 70,703 26 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney